← All Goodrx Holdings, INC filings

Goodrx Holdings, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
GDRX
Goodrx Holdings, INC
10-K: GoodRx Navigates Evolving Healthcare Landscape, Reports Modest Growth
GoodRx Holdings, Inc. reported a 1% revenue increase in 2025, driven by strong pharma direct growth despite challenges in prescription transactions and a changing retail pharmacy landscape.
NASDAQ
GDRX
Goodrx Holdings, INC
10-K: GoodRx Holdings Reports 6% Revenue Increase for 2024, Focuses on Growth and Efficiency
GoodRx Holdings, Inc. reports a 6% increase in revenue for 2024, driven by growth in prescription transactions and pharma manufacturer solutions, while navigating a changing retail pharmacy landscape.
NASDAQ
GDRX
Goodrx Holdings, INC
10-K: GoodRx Holdings Outlines Capital Structure and Governance in SEC Filing
GoodRx Holdings details its dual-class stock structure, board composition, and anti-takeover provisions in a recent SEC filing.